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The calcium-binding protein calretinin has emerged
as a useful marker for the identification of mesothe-
liomas of the epithelioid and mixed types, but its
putative role in tumor development has not been ad-
dressed previously. Although exposure to asbestos
fibers is considered the main cause of mesothelioma,
undoubtedly, not all mesothelioma patients have a
history of asbestos exposure. The question as to
whether the SV40 virus is involved as a possible co-
factor is still highly debated. Here we show that in-
creased expression of SV40 early gene products in the
mesothelial cell line MeT-5A induces the expression
of calretinin and that elevated calretinin levels strongly
correlate with increased resistance to asbestos cytotox-
icity. Calretinin alone mediates a significant part of this
protective effect because cells stably transfected with
calretinin cDNA were clearly more resistant to the toxic
effects of crocidolite than mock-transfected control
cells. Down-regulation of calretinin by antisense meth-
ods restored the sensitivity to asbestos toxicity to a large
degree. The protective effect observed in clones with
higher calretinin expression levels could be eliminated
by phosphatidylinositol 3-kinase (PI3K) inhibitors, im-
plying an important role for the PI3K/AKT signaling
(survival) pathway in mediating the protective effect.
Up-regulation of calretinin, resulting from either asbes-
tos exposure or SV40 oncoproteins, may be a common
denominator that leads to increased resistance to asbes-
tos cytotoxicity and thereby contributes to mesotheli-
oma carcinogenesis.
Malignant mesotheliomas are tumors of the serosal lining
of the pleural, pericardial, and peritoneal cavities causing
more than 2000 deaths per year in the US alone.1,2
Current therapy is ineffective in slowing the time course of
the disease and median survival from the time of diag-
nosis is rarely greater than 1 year. Mesothelioma is most
often associated with asbestos exposure.3,4 Because ex-
posure to fibers of the amphibole subgroup (crocidolite,
amosite) is linked to mesothelioma and lung cancer de-
velopment,5 crocidolite is often used in experimental
studies to investigate asbestos-related damage.3 Al-
though asbestos is not considered as a classical muta-
genic agent,2 the way it causes malignant transformation
is still under debate. Approximately 80% of mesothelioma
patients have a history of asbestos exposure, whereas
20% or more cases remain idiopathic.6 Thus, additional
factors (man-made mineral fibers, ionizing radiation,
SV407) have been proposed to either induce or possibly
act as co-carcinogens for mesotheliomas.8 The most dis-
cussed one is SV40, with many reports supporting a role
for SV40 in mesotheliomas,9–14 but also many question-
ing it15–17 or proposing to perform more, well-designed
epidemiological studies.18 A review panel initiated by the
Institute of Medicine that re-evaluated all epidemiological
studies on a putative link between the distribution of SV40
contaminated vaccines and mesotheliomas or other
types of SV40-associated cancers concluded that there
was no evidence to rule either in favor or against a role of
SV40-contaminated vaccines in mesothelioma and other
tumors.19
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Mesothelial cells are uniquely susceptible to SV40 in-
fection and transformation,1 which is linked to mesothe-
lioma development because intrapleural injection results
in the development of mesotheliomas in 100% of injected
hamsters in 3 to 6 months.20 In humans, SV40 has been
detected in the same type of tumors as the ones ob-
served in animals (mesotheliomas, ependymomas, cho-
roid plexus tumors, and osteosarcomas21). Initial poly-
merase chain reaction (PCR) analyses of human
mesotheliomas showed that SV40 sequences were
present in 60% of the samples10 and the overall consen-
sus is that 50% of malignant mesotheliomas in the US
contain SV40,22 whereas the absence of SV40 in Finnish
specimens was likely attributable to the absence of SV40
contaminations in the used vaccine.23 In another study,
the authors observed the presence of SV40 sequences in
6% of specimens; their prior detection in a higher per-
centage of specimens was interpreted as resulting from
laboratory contamination by SV40 plasmids.16
Evidence for SV40 acting as a co-carcinogen came
from studies demonstrating that SV40 large T antigen
(Tag) confers a protective effect on cells exposed to
crocidolite. Although addition of crocidolite to cultured
human mesothelial cells normally results in massive cell
death, concomitant transfection with SV40 Tag leads to
foci formation and increased cell survival.1 Tag is a 90-
kDa protein that is directly mutagenic by altering the
karyotype and the stability of the host genome; it acts in
conjunction with the small t antigen (tag), a 17-kDa pro-
tein localized in the cytoplasm that inhibits phosphatase
2A, stimulates MAP kinase, and helps Tag in binding/
inactivating cellular tumor suppressors including the ret-
inoblastoma family members pRb, p107, p130, and also
the tumor suppressor p53.2 In transgenic mice expressing
Tag selectively in mesothelial cells, asbestos-induced me-
sothelioma formation shows a dose dependency: in a trans-
genic line with a high copy number of integrated transgene,
tumors develop faster and are more invasive than in a
single-copy line.24 Besides sequestering and thereby in-
activating tumor suppressors, novel mechanisms involv-
ing Tag in the process of transformation have been re-
cently reported. Tag in a complex with p53, pRb, and
p300 binds and activates the insulin-like growth factor I
promoter and thus regulates transcription of insulin-like
growth factor I25 and it is proposed that this multiprotein
complex promotes growth of malignant cells through its
ability to activate the insulin-like growth factor I signaling
pathway. Furthermore, Tag also binds to insulin receptor
substrate 126 and insulin receptor substrate 1 binding to
Tag appears necessary for Tag-mediated phosphoryla-
tion of AKT. Thus, Tag is suggested to inhibit apoptosis
via the activation of PI3K/AKT signaling.
A protein detected in essentially all mesotheliomas of
the epithelioid and mixed type, while present only in a
small percentage (10%) of lung adenocarcinomas is
calretinin, a calcium-binding protein of the EF-hand fam-
ily.27,28 The authors reporting this initial finding came to
the conclusion that calretinin was an extremely useful
positive marker for the distinction between these two
tumor types; consequently, calretinin antibodies together
with a large panel of other antibodies either serving as
positive or negative markers have gained wide accep-
tance for the diagnosis of mesotheliomas. Yet, no pub-
lished study has directly addressed the question whether
the expression of calretinin in mesotheliomas is linked
(directly or indirectly) with the process of transformation.
In healthy individuals, this protein is mainly expressed in
a specific subset of neurons.29–31 The precise physiolog-
ical function of calretinin is still unknown; a role in intra-
cellular Ca2 homeostasis and/or Ca2 buffering has
been suggested in nerve cells.32 In nonexcitable colon
cancer cells, calretinin interacts with cytoskeletal ele-
ments.33 A correlation exists between the expression of
calretinin and cell proliferation in certain colon cancer
cells; down-regulation of calretinin in WiDr cells blocks
the cell cycle and increases apoptosis.34 Calretinin is not
expressed in normal enterocytes; it is also absent in
normal simple squamous epithelium of the peritoneal
cavity consisting of mesothelial cells in situ,27 but is
present in reactive mesothelial cells35 and benign multi-
cystic mesothelioma.36 However, its putative role in car-
cinogenesis is still unclear.
Here we tested the hypothesis that up-regulation of
calretinin in mesothelial cells contributes to the escape
from cell death as proposed for calretinin-expressing
colon carcinoma cells,34 which then favors additional
genetic alterations leading to malignant transformation.
Materials and Methods
Cell Culture
Two different MeT-5A cell lines (mesothelial origin, hu-
man, immortalized with SV40 early region genes) were
used for the experiments: one directly obtained from the
American Type Cell Collection (ATCC; Rockville, MD)
named MeT-5A-ATCC, the other was a clone received
from Geneva Hospital, Geneva, Switzerland (MeT-5A-
GE). The cells were grown at 37°C/5% CO2 in Dulbecco’s
modified Eagle’s medium/F-12 1:1 plus GlutaMax (Gibco,
Basel, Switzerland) supplemented with 10% fetal calf
serum (Gibco) and antibiotics (100 U/ml penicillin; 100
g/ml streptomycin).
Isolation of Genomic DNA from MeT-5A Clones
and Semiquantitative Determination of
Transgene Copy Number
Genomic DNA (0.5 g) from MeT-5A cells (ATCC and GE
clones) was isolated using standard methods and used
to either amplify exon 1 of SV40 Tag or intron 9 of the
human calretinin (CALB2) gene. The latter signal was
used for normalization. Sequences of primers for Tag and
calretinin were: SV40Ex1-5 (5-CAGAGAGGAATCTTTG-
CAGCTAATGG-3), SV40Ex1-3 (5-AAGCCTCCAAAGT-
CAGGTTGATGAGC-3) and CR-It9410F (5-GGTGGTTT-
TCTTCATAACCAGTGTTGG-3), CR-It9665R (5-TAAGA-
GTCTAGCCTCTCCATTACTCTG-3). A limited number of
PCR cycles were performed (annealing: 66°C, 25 cycles)
and the PCR amplicons were separated on a 2% agarose
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gel. The signal intensities were quantitatively analyzed by
the Gene Tools (Syngene, Cambridge, UK) software.
Immunohistochemistry
Cells were grown on laminin-treated glass coverslips and
fixed with 4% paraformaldehyde, 15% (v/v) saturated
picric acid, and 0.38% glutaraldehyde in a 0.2 mol/L
sodium phosphate buffer, pH 7.3. They were then incu-
bated with either calretinin antibody CR7696 (1:1000)37
or Tag antibody (Pab101, 1:500; Santa Cruz, Biotechnol-
ogy, Santa Cruz, CA) for 16 hours at room temperature in
0.1 mol/L Tris-buffered saline, pH 7.3, containing 10%
bovine serum. The secondary biotinylated antibody (1:
200; Vector Laboratories, Burlingame, CA) was added for
2 hours at room temperature in 0.1 mol/L Tris-buffered
saline, pH 7.3, containing 10% bovine serum, followed by
incubation with the avidin-biotin complex (Vector) diluted
1:200. The antibody complex was visualized by incuba-
tion with 3,3-diaminobenzidine-HCl-hydrogen peroxide.
Western Blot Assays for Calretinin and Tag
Cells were washed with Ca2- and Mg2-free (CMF)-
phosphate-buffered saline, removed from the culture
flasks with a cell scraper, and resuspended in 10 mmol/L
Tris-HCl, 2 mmol/L ethylenediaminetetraacetic acid, pH
8.0. Cells were disrupted by ultrasonication for 20 sec-
onds, the suspension was centrifuged (13,000  g, 4°C,
30 minutes) and the supernatant was recovered. Protein
concentrations were determined by the Bradford method
using the reagent from Bio-Rad (Hercules, CA) and bo-
vine serum albumin as standard. Protein samples were
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (12.5%) and transferred onto nitrocellu-
lose membranes (BDH Laboratory Supplies, Dorset, UK)
using a semidry blotting apparatus (Bio-Rad). Mem-
branes were stained with Ponceau S (Sigma, Buchs,
Switzerland) to check for even loading of the gels and
then further processed as described before38 using
CR7696 antibody (1:1000) or anti-Tag antibody (1:500).
For normalization of the Western blots, densitometric
analysis of the Ponceau S-stained membranes using the
GeneTools software was performed. This decreases the
bias toward a specific protein (eg, GAPDH, -actin) often
used for normalization that might also be affected by the
experimental manipulations.39,40 Calretinin expression
was quantified as the blackening of the enhanced chemi-
luminescence films in several separate experiments us-
ing the GeneTools software; the data were log-trans-
formed for the analyses. Because only a subset of clones
were assayed in any particular replication of the experi-
ment, to avoid a bias, we estimated calretinin expression
levels of each clone as least-square means from a two-
way analysis of variance with clone and experiments as
factors. For graphical presentation the least-square
means were back-transformed and expressed on a rela-
tive scale such that the calretinin expression for the SV40
clone SV8  100.
Asbestos Toxicity Assays
We quantified the resistance of control and transfected
clones to asbestos toxicity, and the effects of the PI3K-
inhibitors PI103 and ZSTK474,41 the inhibitor of mTOR
(rapamycin) and the inhibitor of ERK1/2 (PD98059). A
standard type of asbestos, NIEHS crocidolite obtained
from Dr. Brooke T. Mossman, Department of Pathology,
University of Vermont, Burlington, VT, was used. Crocido-
lite asbestos fibers were suspended in Hanks’ balanced
salt solution (1 mg/ml), triturated 10 times through a 22-
gauge needle to obtain a homogenous suspension and
added directly to the medium.42 Cells were seeded in
96-well plates (1000 to 5000 cells/well) and allowed to
attach for 24 hours before treatment. The number of
viable cells in culture was determined with the MTT as-
say.43 Initial growth curves of various transfected clones
were obtained in the absence of any treatment. In assays
of crocidolite toxicity, crocidolite (10.0 or 7.5 g/cm2)
was added 24 hours after plating, and the cell number
was assessed 5 days later; parallel, untreated cultures
served as controls. For the assay of crocidolite resistance
in the presence of inhibitors of signaling pathways, cells
were incubated for 1 hour with PI103 (750 nmol/L),
ZSTK474 (1 mol/L), rapamycin (10 nmol/L; all kind gifts
of Matthias Wymann, University of Basel, Basel, Switzer-
land) or PD98059 (20 mol/L; Cell Signaling Technology,
Bioconcept, Allschwil, Switzerland) before the addition of
crocidolite (5 g/cm2); the number of viable cells was
determined 48 hours later. All clones tested in a given
assay were grown in 96-well plates, with several repli-
cate wells per clone and treatment (generally n  7); the
entire assay was replicated four times. Pilot experiments
verified the linearity between cell number (determined
by cell counting) and optical density (OD) 540-nm mea-
surements (see Supplemental Figure S1 at http://ajp.
amjpathol.org). Resistance to crocidolite toxicity was
quantified as the OD (reflecting the number of viable
cells) in cultures treated with crocidolite, relative to the
OD of untreated cultures of the same clone. As is appro-
priate for ratio data, the analysis was performed on the
log scale. OD values were log-transformed and averaged
over replicate wells containing a given clone within each
microtiter plate. Crocidolite resistance was compared
among different types of clones (such as mock-trans-
fected, calretinin-transfected, and SV40-transfected) with
an analysis of variance, whereby individual clones were
treated as a random factor nested within clone types and
replicate assays were treated as blocks. Analogous ap-
proach was used to analyze the effects of treatment with
PI103, ZSTK474, rapamycin, and PD98059. The analysis
was performed with PROC GLM of SAS (Cary, NC) sta-
tistical software. For graphical representation, the mean
OD values for a given cell line and treatment were back-
transformed and expressed as percent of the OD of
untreated control.
Plasmids
To allow for the production of stably transfected cells, the
plasmid pCMV-Tag (kind gift of Sandro Rusconi, Univer-
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sity of Fribourg, Fribourg, Switzerland) containing the
SV40 early region genes was modified. The neor cassette
was synthesized by PCR using the primers NEO-TOT5/
NHE (5-TACAGCTAGCTTGAATTCTACCGGGTA GG-3),
NEO- TOT3/NHE (5-CGGTAGCTAGCTTCTGATGGAA-
TTAGAAC-3) and the previously described neor cas-
sette44 as template. The PCR fragment contained termi-
nal NheI sites that allowed insertion into the unique NheI
site in pCMV-Tag. The PCR amplicon was digested with
NheI and ligated into pCMV-Tag. The final construct
pCMV-Tag-NEO was linearized using the unique site
AccI. For the production of stably calretinin-transfected
MeT-5A-GE cells, the previously described SacI-linear-
ized plasmid RSV-CR-NEO was used.45
Stable Gene Transfer
Plasmids were diluted in OptiMem (Gibco) and transfec-
tions were performed according to the manufacturer’s
protocol using Lipofectamine 2000 (Invitrogen, Life Tech-
nologies, Basel, Switzerland). Twenty-four hours after
transfection, cells were treated with 0.75 mg/ml of G418
for 10 days and surviving cells were diluted in 96-well
plates to isolate clones deriving from a single cell. The
dilution procedure was repeated once.
Isolation of RNA and Reverse Transcription
(RT)-PCR
Total RNA (5 g) isolated by the guanidinium thiocya-
nate-phenol-chloroform method was used for RT-PCR
using random primers (Revert Aid H Minus Strand cDNA
synthesis kit; Fermentas, Glen Burnie, MD). Amplification
of glyceraldhyde-phosphate dehydrogenase (GAPDH)
using the two oligodeoxynucleotides 5-GAGCTGAA-
CGGGAAGCTCACTGG-3 and 5-CAACTGTGAGGAG-
GGGAGATTCAG-3 (annealing: 55°C, 25 cycles) served
as positive control. The primers used for detecting cal-
retinin mRNA were 5-GACAGGAGTGGCTACATCGA-
AGCCAATGAG-3 and 5-GGCATCCAGCTCATGCTCG-
TCAATGTAGCC-3 (annealing: 66°C, 25 cycles). Aliquots
of each RT-PCR reaction containing the amplified frag-
ments were separated on a 2% agarose gel.
Cell-Based Enzyme-Linked Immunosorbent
Assay for AKT
Protein phosphorylation of signaling molecules was di-
rectly measured in 96-well cultured cells (CASE; Super-
Array Bioscience, Frederick, MD). Cells (12,000 cells/
well) were seeded into 96-well plates and 24 hours later
treated with crocidolite (5 g/cm2, 1 hour). The cells were
then fixed with 4% formaldehyde to preserve any activa-
tion-specific protein modification and further processed
according to the manufacturer’s protocol. The amount of
phosphorylated protein, once normalized to the amount
of total protein, is directly related to the extent of down-
stream pathway activation. The ratios pAKT/AKT were
log-transformed and analyzed in an analysis of variance.
Down-Regulation of Calretinin Expression in CR
Clones Using Antisense Oligonucleotides
(ASOs) and CR siRNA
For the calretinin down-regulation experiments, cells
were seeded into 96-well plates (2000 cells/well) and
grown for 24 hours. The antisense oligo CR-AS9 (5-
TCTCGATTTTCCCATCTGA-3) was added (300 nmol/L)
using Lipofectamine 2000 (Invitrogen) as transfection re-
agent. Controls were transfected with an unrelated non-
sense oligo (300 nmol/L; NSO 5-AAGAAACTGGGGAG-
GCTTCGCAGAGGGATG-3). After incubation for 24
hours, crocidolite (2.5 g/cm2) was added and 48 hours
later the MTT assay was performed. The siRNA (PRED
siRNA Hs CALB2; Qiagen, Hombrechtikon, Switzerland)
was used at a final concentration of 10 nmol/L and was
delivered into the cells also using Lipofectamine 2000.
Control cells were treated with 10 nmol/L of the same
control oligo as above and crocidolite toxicity was deter-
mined as for the ASO.
Results
Up-Regulation of Calretinin in MeT-5A-GE Cells
after Transfection with pCMV-SV40-NEO
Plasmid
Two clones of SV40 early region genes-immortalized me-
sothelial cells, MeT-5A-ATCC and MeT-5A-GE, were ana-
lyzed. Morphologically they were very similar, with an adher-
ent phenotype and growing as a monolayer as previously
described for the MeT-5A-ATCC clone (Figure 1).46 Cells of
the GE clone were somewhat flatter, more spread out
than the ATCC cells and filiform processes were more
pronounced. Although immunoreactivity was very weak
for calretinin and almost undetectable for Tag in the GE
clone (Figure 1A), the ATCC clone showed strong stain-
ing for both calretinin (diffuse cytosolic staining) and Tag
(nuclear staining); findings that were supported by West-
ern blot analyses (Figures 1B and 2A). The weaker Tag
expression in the GE clone is likely related to the smaller
copy number of inserted transgenic elements. Semiquan-
titative PCR analysis of the 5 region (exon 1) of Tag
sequences in the genomic DNA isolated from both clones
revealed the signal to be 20- to 50-fold stronger in the
ATCC clone (Figure 1C).
The parallel differences in Tag and calretinin expres-
sion levels between the two MeT-5A clones suggested
that Tag and/or tag could induce expression of calretinin.
To test this hypothesis, we stably transfected MeT-5A-GE
cells with the plasmid pCMV-Tag-NEO, containing the
SV40 early genes under the control of the CMV promoter.
Western blot analysis of transfected cells that survived
the G418 selection revealed the calretinin signal to be
approximately twofold higher than in the parental MeT-
5A-GE cells (see Supplemental Figure S2 at http://ajp.
amjpathol.org). Eighteen clones were obtained (SV1 to
SV18), each derived from a single transfected cell that
showed strong immunoreactivity for Tag. In addition, two
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Tag-negative clones (M2, M3) served as additional con-
trol (mock-transfected) clones besides the untransfected
GE line. The genomic DNA from all clones contained the
neor cassette used as a selection marker confirming the
integration of the plasmid DNA into the genome (data not
shown) and furthermore Tag copy numbers of clones SV1
and SV8 were similar as in the ATCC clone (Figure 1C).
Expression levels of Tag and calretinin were analyzed
semiquantitatively by Western blot analysis (Figure 2A,
for normalization of Western blot signals, see Supplemen-
tal Figure S3 at http://ajp.amjpathol.org). Although both
Tag and calretinin protein levels were very low in the
untransfected GE cells, all clones with high Tag expres-
sion also had considerably higher calretinin expression
levels than the GE cells. No increase in calretinin was
detected in clones with low Tag expression (M2, M3)
used as controls. Clones with high Tag expression (SV1,
SV8, and SV11) had calretinin levels comparable with the
ATCC clone. A close correspondence was observed be-
tween signal intensities in the calretinin RT-PCR reactions
and the calretinin Western blots in a subset of clones
indicating control at the transcriptional level (Figure 2A,
bottom gel). The stability of calretinin expression in the
SV40-transfected clones was tested 10 passages later.
Results from Western blot analysis were virtually identical
(not shown) and thus, all further experiments were per-
formed with cells with no more than 10 additional pas-
Figure 1. Immunohistochemistry and Western blot analysis for calretinin
(CR) and T large antigen (Tag) in the two mesothelial cell clones MeT-5A-
ATCC and MeT-5A-GE. A: Fixed cells were either H&E-stained (top), or
immunostained for T large antigen (Tag, middle) or calretinin (CR, bottom).
Immunostaining for both CR and Tag was stronger in the ATCC clone than in
the GE clone. CR immunoreactivity was seen throughout the cytoplasmic
compartment and also the nucleus, whereas Tag expression was essentially
nuclear. B: The Western blot signals for both CR and Tag were much
stronger in the ATCC clone compared with the GE clone. C: PCR for Tag
exon 1 using genomic DNA resulted in strong signals for the ATCC clone
and the SV40-Tag-transfected GE clones SV1 and SV8 (for details, see
Results), whereas the signal for the parental GE clone (two independent
DNA isolations) resulted in much weaker signals. Semiquantitative anal-
ysis of the PCR signal under nonsaturating conditions (signal not reaching
the plateau) for the ATCC clone revealed the GE signal to be 20- to 50-fold
weaker reflecting the smaller copy number of Tag plasmid inserts in the
GE clone. A control PCR reaction with only bidistilled H2O as input did
not yield a detectable PCR signal.
Figure 2. Western blot and RT-PCR analysis of SV40-transfected MeT-5A-GE
cells and growth curves of various MeT-5A-GE clones. A: Relative protein
expression levels determined by Western blot analysis of Tag (top) and
calretinin (CR, middle) were strongly linked. The Ponceau S-stained mem-
brane used for the normalization of the signals is shown in Supplemental
Figure S3 at http://ajp.amjpathol.org). Tag levels in SV40-transfected
MeT5A-GE clones SV5, SV4, SV1, SV8, SV9, and SV11 were considerably
higher than in control cells GE, M2, and M3. CR levels in clones SV1, SV8, and
SV11 were similar as in the ATCC clone, whereas CR levels of SV5 and SV9
were lower, yet still higher than in the three controls. The protein recognized
by the calretinin antiserum in clone SV4 had a higher molecular weight
indicative of aberrant integration and/or expression and was not used in
further experiments. Semiquantitative RT-PCR (25 cycles) using total RNA
from the various clones revealed a close correlation between mRNA and
protein levels (bottom) suggestive of transcriptional control of expression.
For the normalization, the GAPDH signal obtained under identical experi-
mental conditions (25 cycles) was used. B: Growth curves of selected MeT-
5A-GE clones determined by MTT assay showed no correlation with either
CR or Tag expression levels (for details, see Results section). Cells (1500 per
well) were seeded in 96-well plates (eight wells per clone, three experi-
ments) and incubated for 1, 2, 4, or 7 days. Scale bar  20 m.
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sages. We therefore conclude that Tag expression stably
up-regulates calretinin expression in transfected me-
sothelial cells.
Cell Growth of SV40-Transfected MeT-5A-GE
Cells Is Not Correlated with Calretinin
Expression Levels
The cell growth of SV40-transfected MeT-5A-GE cells
was compared with mock-transfected and control cells
and averaged growth curves from three experiments are
shown in Figure 2B. The number of viable cells was
determined 1, 2, 4, and 7 days after plating. None of the
transfected clones exhibited faster growth than the un-
transfected control cells. Although most cell lines were
growing somewhat slower, the calretinin-negative control
clone M3 and the high calretinin-expression clone SV11
were growing as fast as the untransfected control cells.
No correlation existed between calretinin/Tag expression
levels and proliferation rate. Nonetheless, the small dif-
ferences in proliferation rates among the various clones
were taken into consideration for the cytotoxicity experi-
ments (see below).
Effect of Crocidolite Treatment on Cell Survival
of SV-40-Transfected MeT-5A-GE Cells
It has been proposed that SV40 Tag might act synergis-
tically with asbestos fibers on the pathogenesis of malig-
nant mesothelioma, by counteracting the cytotoxic ef-
fects of asbestos fibers, thus allowing the resistant
clones to slowly accumulate additional protective muta-
tions.2,24,47 Therefore, the susceptibility of SV40 early
genes-transfected MeT-5A-GE clones to asbestos fiber-
induced cell death was investigated at various crocidolite
concentrations (7.5, 10, and 12.5 g/cm2), similarly as
described before for rat pleural mesothelial cells.48 Three
clones were initially selected: the control clone M3, clone
SV5 (low calretinin expression), and clone SV8 (high
calretinin expression). For each clone, the MTT signal at
day 5 of cell culture in the absence of crocidolite was
defined as 100% to account for the slight variations in cell
growth between clones as shown before (Figure 2B).
Crocidolite treatment led to a strong, dose-dependent
reduction of viable cells in all clones (Figure 3A); at all
doses tested survival of the high-calretinin expressing
clone SV8 was better compared with the two other clones
(analysis of variance, followed by Tukey test; P  0.05 at
all concentrations). Thus, we conjectured that up-regula-
tion of calretinin in MeT5A-GE clones observed after
transfection with early region SV40 genes might protect
the cells against crocidolite toxicity. The cell morphology
of MeT-5A cells was considerably affected by the cro-
cidolite treatment irrespective of the clone type; cells
were either more flattened compared with untreated
cells or were more rounded and often shrunk. The latter
were characterized by dark pycnotic nuclei and some-
times by cytoplasmic blebbing characteristic of apo-
ptotic cells. In some cells strongly lobulated and frag-
Figure 3. Crocidolite toxicity and morphological changes in asbestos-treated MeT-5A clones. A: The dose-dependant effect of crocidolite-mediated cytotoxicity
was assessed in MTT assays. The number of viable cells decreased by incubating cells with higher crocidolite concentrations. Although the number of viable cells
was similar for the control cells M3 and clone SV5 with relatively low calretinin expression levels, at all crocidolite doses tested (7.5, 10, and 12.5 g/cm2), clone
SV8 with high calretinin expression levels was significantly more resistant to asbestos-mediated cytotoxicity (values are mean	 SE, analysis of variance on relative
OD with crocidolite versus untreated cells: 7.5 g/cm2: F2,33  10.7, P  001, Tukey test, *P  0.05: SV8 
 M3  SV5; 10 g/cm
2: F2,33  28.9, P  0.001; Tukey
test, *P  0.05: SV8 
 M3 
 SV5 and 12.5 g/cm2: F2,33  12.4, P  0.001, Tukey test, *P  0.05: SV8 
 M3  SV5). B: Altered morphology of crocidolite-treated
MeT-5A cells includes cell flattening, ie, increased surface (1), condensed pycnotic nuclei (2), blebbing of the plasma membrane (3), and lobulation combined
with fragmentation of the nucleus (4). Asbestos fibers were engulfed in cells, often surrounding the nucleus (arrows), within the nucleus (arrowhead), or present
as large rod-like structures (asterisk) loosely attached to the outer cell surface. C: SV40-transfected MeT-5A GE clones with higher calretinin (CR) expression levels
(filled circles) were more resistant to crocidolite toxicity than either low-expressing clones (gray diamonds), mock-transfected clones M2 and M3, or the parental
untransfected GE cells (open circles). Crocidolite resistance of the eight analyzed clones was positively correlated with CR expression (Pearson’s r  0.75, P 
0.032). The percentage of viable cells was determined by MTT assay 5 days after exposure to crocidolite (10 g/cm2). Scale bar  20 m.
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mented nuclei were observed. Asbestos fibers were
either engulfed in the cells, often surrounding the nu-
cleus or even localized within the nucleus or present as
large rod-like structures loosely attached to the outer
cell surface (Figure 3B).
To address further the relationship between SV40
transfection, calretinin expression, and crocidolite toxic-
ity, we studied the effect of a toxic dose of crocidolite
(10.0 g/cm2, 5 days exposure) on cell culture growth in
eight clones with different calretinin expression: five
SV40-tranfected clones, two mock-transfected clones,
and the original MeT-5A-GE line. Thus, this measure of
resistance reflects the net effect of the treatment on cell
mortality and cell division. Across these eight clones, the
resistance to crocidolite was positively correlated with
calretinin expression (Figure 3C; Pearson’s r  0.75, P 
0.032). In particular, three SV40-transfected clones with a
high calretinin expression (SV1, SV8, SV11) survived the
crocidolite treatment considerably better than the two SV40
clones with low calretinin expression (SV5, SV9; F1,3 
108.0, P 0.002). In the latter two SV40 clones the crocido-
lite resistance was similar to that of the untransfected control
(GE) or the mock-transfected clones M2 and M3. Thus,
transfection of MeT-5A-GE cells with SV40 early genes en-
hances crocidolite resistance only if accompanied by cal-
retinin up-regulation.
Increased Calretinin Expression Protects
MeT-5A from Crocidolite-Induced Cytotoxicity
The positive correlation between calretinin expression
in SV40-transfected cell lines and their resistance to
crocidolite suggested a protective role of calretinin.
Alternatively, increased calretinin expression could be a
by-product of other SV40-induced changes; SV40-trans-
fection is known to lead to altered expression of several
other genes implicated in cell-cycle control/cell growth.49
To discern between these alternatives, we tested whether
elevated calretinin expression suffices to enhance resis-
tance to crocidolite in the absence of elevated Tag levels.
For this, MeT-5A-GE cells were stably transfected with
the plasmid RSV-CR-NEO that yielded 45 G418-resistant
clones. Ten of these clones spanning the whole range of
calretinin expression levels were chosen for the crocido-
lite cytotoxicity assays (Figure 4A); the most resistant
SV40-transfected clones SV1 and SV8 served as positive
controls, whereas the mock-transfected clones M2 and
M3 were used as negative controls. Cell cultures were
treated with 7.5 g/cm2 of crocidolite for 3 days and the
number of viable cells was determined by the MTT assay.
The resistance of those cell lines is plotted in Figure 4B
against their calretinin expression levels (estimated by
Western blots). Despite significant variation in the resis-
tance among the calretinin-transfected clones (F9,18 
2.9, P  0.028), as a group these clones were signifi-
cantly more resistant than the two mock-transfected
clones (F1,11  5.6, P  0.038), although not as resistant
as the two highly resistant SV40 clones (F1,11 10.2, P
0.009). Although some of the calretinin-transfected
clones had low crocidolite resistance despite high cal-
retinin expression, none of the clones with low expression
showed high resistance. Among the six calretinin-trans-
fected clones with the lowest calretinin expression there
was a significant correlation between crocidolite resis-
tance and calretinin expression (Pearson’s r  0.87, P 
0.025). Thus, among those cell lines, enhanced calretinin
expression seemed necessary, although not entirely suf-
ficient for improved resistance to crocidolite, although
Figure 4. Comparison of calretinin (CR) expression levels and cell survival of
MeT-5A-GE cells stably transfected with the expression plasmid RSV-CR-
NEO. A: A representative Western blot is shown in the upper panel and the
relative quantitative results are depicted in the bottom panel (average of
three Western blots and three samples for each clone). Five clones with high
CR expression (dark gray bars) and five with low CR expression (light gray
bars) were compared with pCMV-Tag-transfected ones with high CR expres-
sion (SV40 clones SV1 and SV8, black bars) and to the negative controls (M2
and M3, white bars) by Western blot analyses. Relative CR expression levels
in the high CR group were comparable with levels in the SV40 group,
whereas levels in the low CR group were on average only slightly higher than
in control clones M2 and M3. B: The resistance to asbestos cytotoxicity was
determined by the MTT assay and results are the mean from three experi-
ments. The relationship between CR expression and the survival of cells after
crocidolite treatment is shown for 10 CR-transfected clones (gray diamonds),
two mock-transfected controls (open triangles), and two SV40-transfected
clones (black circles). A regression line is shown for the six CR clones with
the lowest CR expression levels (Pearson’s r  0.87, P  0.025). C: Western
blot of Tag (arrow) in SV40 clones (SV1, SV8, and SV11) in comparison with
CR-transfected clones and the control clones M2 and M3. No signal for Tag
was detectable in any of the CR clones indicating that calretinin up-regulation
does not induce Tag expression. The lower nonspecific band in all samples
is attributable to an endogenous biotinylated protein. Bars on the left indicate
the position of molecular marker proteins (from top to bottom: 100 kDa, 75
kDa, 50 kDa).
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their resistance was not as strong as observed in the two
SV40 clones. Because increased Tag expression was
associated with elevated calretinin levels (Figure 2A),
which was in part responsible for the cytoprotective ef-
fect, we wanted to ascertain that the protective effect
seen in the CR clones was not mediated by reciprocal
up-regulation of Tag in the CR clones. Western blot anal-
ysis revealed a strong Tag signal only in the Tag-trans-
fected SV1, SV8, and SV11 clones used as positive con-
trols, whereas all CR clones were essentially negative,
similar as the control clones M2 and M3 (Figure 4C). As
described above, neither the mock clone nor the CR
clones were completely Tag-negative, but below the de-
tection level of Western blot analysis, when loading iden-
tical amounts of total protein as in the Tag-transfected
SV1, SV8, and SV11 clones. Therefore, the protective
effect seems to have been mediated by calretinin itself,
independent of Tag. To further verify this hypothesis, we
down-regulated calretinin expression in CR clones using
two different antisense technologies. In the first one, we
used CR antisense oligonucleotides (ASOs) previously
demonstrated to down-regulate calretinin expression in
colon cancer cell lines (S. Vonlanthen and B. Schwaller,
unpublished).34 The most efficient oligonucleotide CR9-
ASO was tested in clones SV1 and SV8. The addition of
CR9-ASO led to a concentration-dependent decrease in
calretinin levels after 48 hours, and an80% reduction of
calretinin expression was achieved by 300 nmol/L CR9-
ASO in clone SV1 (Figure 5, A and B); this effect was less
pronounced in clone SV8, which had a higher initial cal-
retinin expression (Figure 5B). However, calretinin ex-
pression levels after addition of CR9-ASO were still
higher than in control clones M2 and M3. The control
oligo (NSO; 300 nmol/L) did not affect calretinin expres-
sion levels (not shown). A similar down-regulation of cal-
retinin was also observed in clone SV8 treated with CR
siRNA (5, 20 nmol/L) for 24 hours and 48 hours (Figure
5A, top). The asbestos cytotoxicity assay was per-
formed with four CR and two control clones. In the
presence of crocidolite, the MTT signal of CR clones
treated with ASO compared with control NSO-treated
cells was on average reduced by 11 to 26% (treatment
F1,3  28.0, P  0.013), and was similar for all CR
clones (treatment  clone interaction F3,21  0.1, P 
0.95 ; Figure 5C). The effect was of similar magnitude
(20%) as the protection initially brought about by
calretinin: compare with Figure 4B and with Figure 6A;
middle bars (crocidolite-treated) in the control and CR
clones. The ASO-mediated effect was minimal or absent
in control clones M2 and M3 (F1,1  0.0, P  0.92),
clones with already very low calretinin expression levels
(Figure 2A). The siRNA treatment resulted in a similar (10
Figure 5. Down-regulation of calretinin by antisense methods decreases
survival of crocidolite-treated CR clones. A: Western blot of cytosolic proteins
isolated from clone SV8 (top) after treatment with calretinin siRNA (0, 5, and
20 nmol/L) for 24 hours (left) or 48 hours (right) or clones SV1 (left) and
SV8 (right) incubated with antisense oligonucleotides (CR9-ASO; 0, 60,
and 300 nmol/L; 48 hours; bottom); the bars indicate the position of marker
proteins of 50 kDa (upper bar) and 25 kDa (lower bar). B: Calretinin
expression levels were reduced by 80% in clone SV1 after exposure to 300
nmol/L CR9-ASO for 48 hours. On average, expression levels were still
somewhat higher than in control clones M2 and M3. The relative values for
clones SV1 and SV8 (untreated) and M2 and M3 were obtained from Western
blots as shown in Figure 4A; clone SV8 was set to 100%. C: Quantitative
analysis of the effect of calretinin down-regulation by CR9-ASO on crocido-
lite cytotoxicity in comparison with NSO-treated (control) cells. For the
analysis, the OD values were log-transformed, averaged over replicate wells
with the same clone and treatment within an experiment, and subjected to an
analysis of variance, with treatment, clone, and their interaction as factors,
and experiment (multiwell plate) treated as block. Clone was treated as a
random factor, and so treatment  clone interaction was used as the denom-
inator in the F-test for the effect of treatment. For the graphical representation
the means were back-transformed and differences are presented as percent-
age changes. The MTT signal was decreased in the four CR9-ASO-treated CR
clones on average by 11 to 26% (treatment F1,3  28.0, P  0.013), but not
in the CR9-ASO-treated control clones M2 and M3 (F1,1  0.0, P  0.92).
D: In siRNA-treated clones, the variability was larger with respect to clones
(F3,21  8.2, P  0.001) and replicate experiments (F3,21  74.2, P 
0.001), but compared with NSO controls, siRNA treatment consistently
reduced the MTT signal of all four CR9-ASO-treated CR clones by 10 to
16% (the effect of treatment F1,3  87.8, P  0.003, treatment  clone
interaction F3,21  0.1, P  0.99). This effect was absent in the control
clones M2 and M3 (F1,1  2.8, P  0.34).
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to 16%) increase in the sensitivity to crocidolite toxicity in
the CR clones (treatment F1,3  87.8, P  0.003; treat-
ment  clone interaction F3,21  0.1, P  0.99) (Figure
5D). As for ASO, this effect of siRNA was absent in the
control clones M2 and M3 (F1,1  2.8, P  0.34). When
combining the results of control clones M2 and M3 ex-
posed to CR9-ASO or CR siRNA, the net effect as com-
pared with treatment with control oligo, was close to zero.
Thus, calretinin down-regulation primarily eliminated the
protective phenotype of CR clones—antisense-treated
cells became again more susceptible to the toxic effects
of crocidolite. This further supports calretinin’s protective
effect.
Activation of Signaling Pathways After Asbestos
Exposure and Their Involvement in Protection
Against Cytotoxicity
Exposure of mesothelial cells to asbestos fibers activates
signaling pathways involved in cell survival and cell
death, including the AKT pathway.50 Prolonged exposure
of human mesothelial cells to SV40 increases cell survival
by AKT activation and finally induces transformation ev-
idenced by loss of cell contact inhibition and generation
of several foci.51 We determined the relative phosphory-
lation level of AKT (Ser473) in the control cell lines (GE,
M2, M3), in four SV40-transfected clones (SV1, SV2, SV8,
SV11) and in five calretinin-transfected clones, which
showed a high calretinin expression (CR20, CR21, CR25,
CR34, CR39; Figure 4A). This cell-based enzyme-linked
immunosorbent assay was performed both under basal
conditions and after short-term asbestos exposure (5
g/cm2 for 1 hour). The short-term asbestos exposure led
to an increase of the pAKT/AKT ratio by a factor of 1.5
(F1,9  60.3, P  0.0001); this increase was similar in all
three types of clones (cell type  exposure interaction
F2,9  0.4, P  0.7). Basal pAKT levels differed quite
considerably from one clone to another, the difference
between the lowest and the highest value was almost
twofold. However, analysis of variance revealed that
there were no differences among the three groups (SV40,
CR, and control), neither for basal pAKT levels, induced
levels after crocidolite treatment, nor for the fold induc-
tion; among individual clones there was no correlation
Figure 6. Activation of the AKT signaling pathway is involved in mediating the increased resistance against asbestos-mediated cytotoxicity exclusively in
calretinin-expressing clones A: Both PI103 (0.75 mol/L) and crocidolite (5 g/cm2) reduced the number of viable cells after 48 hours of treatment in all clones.
The effect of PI103 was similar in all clones. A protection against crocidolite treatment was evident in the four SV40-transfected (SV1, SV2, SV8, SV11) and the
five CR-transfected (CR20, CR21, CR25, CR34, CR39) clones (see also Figures 3C and 4B). Crocidolite-induced toxicity in the presence of PI103 was further
increased only in the high CR-expressing clones of the SV40 (F1,3  35.7, *P  0.01) and the CR (F1,3  14.66, **P  0.02) groups. In the control group, the
inhibition of the PI3K/AKT signaling pathway by PI103 treatment did not aggravate the asbestos-induced toxicity. B: Western blot analysis of MeT-5A clones M3
(left) and CR39 (right) treated with 0.5 mol/L or 1 mol/L PI103 for 24 hours; pAKT signals (top, arrow) were considerably reduced at 0.5 mol/L PI103 (
95%
for clone M3) and completely absent at 1 mol/L. For clone CR39 already at 0.5 mol/L PI103 no specific pAKT signal was detected. Total AKT levels (bottom,
arrow) were unaffected by PI103 at the doses tested. The upper band on both blots is a nonspecific signal resulting from an endogenous biotinylated protein.
C andD: Treatment of the same clones as in Bwith the PI3K-specific inhibitor ZSTK474 (C, 1 mol/L) or rapamycin (D, 10 nmol/L), the specific inhibitor of mTOR.
Results with ZSTK474 were almost identical to the ones with PI103 (*P  0.01). Co-incubation of crocidolite and rapamycin resulted in a decreased MTT signal
when compared with crocidolite alone, but the reduction was not different in the three groups (F2,9  0.6, P  0.59). Thus, co-incubation of rapamycin with
asbestos did slightly aggravate asbestos cytotoxicity in all clones (control, SV40, and mock) indicating that neither Tag nor calretinin was involved in this effect.
E: Inhibition of the ERK1/2 signaling pathway with the inhibitor PD 98059 (20 mol/L) did not heighten crocidolite-mediated cytotoxicity in all groups of clones
(main effect F1,9  1.4, P  0.27).
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between pAKT levels and resistance toward crocidolite
cytotoxicity.
To assess whether pAKT signaling plays a role in
resistance to asbestos and whether it depends on cal-
retinin expression, we used the PI3K-inhibitors PI103 and
ZSTK474 to block the AKT-signaling pathway.52 The
Western blot signal for pAKT was dramatically reduced
(to less than 5%) in the presence of 0.5 mol/L PI103,
and was undetectable in the presence of 1 mol/L inhib-
itor, yet total AKT levels were not affected (Figure 6B).
Therefore we chose the concentration of 750 nmol/L to
study the effect of PI103 on crocidolite resistance in a
series of 12 clones: the original GE line and the two
mock clones (which all show low CR expression), four
SV40 clones with high CR expression, and five CR-trans-
fected clones, likewise with high CR expression. In the
absence of crocidolite, 2 days of PI103 exposure re-
duced the number of viable cells by 30% compared
with untreated controls (Figure 6A, white bars); this effect
did not differ significantly among the three categories of
clones (F2,9  3.0, P  0.10), nor did it vary among
clones of the same category (F9,69  0.9, P  0.53).
However, the three categories of clones were affected
differently by the PI103 treatment in the presence of
crocidolite (Figure 6A; PI103 treatment  clone category
interaction, F2,9  5.2, P  0.031). In the clones with low
CR expression (mock clones and untransfected GE cells)
the combination of asbestos and PI103 resulted in an
almost identical survival as in cells only treated with as-
bestos alone. In contrast, blocking the pAKT signaling
with PI103 significantly reduced resistance to crocidolite
in the two sets of clones with high calretinin expression: in
the SV40-transfected cells (F1,3  35.7, P  0.01) and
even more so in the CR-transfected cells (F1,3  14.66,
P  0.02). Because it had been shown before that PI103
not only inhibits PI3K, but also mTOR,53 we applied a
novel PI3K inhibitor ZSTK474 (1 mol/L) that even at
higher concentrations (up to 100 mol/L) only weakly
affects mTOR.41 Results with ZSTK474 and PI103 were
almost identical (Figure 6C). The resistance to crocidolite
in ZSTK474-treated cells was decreased in the SV40
(F1,3  18.0, P  0.024) and CR clones (F1,4  14.4, P 
0.019), but not in the control clones (F1,2 0.0, P 0.95).
That the two calretinin-expressing groups (SV40 and CR)
indeed responded differently from the control group was
supported by the corresponding interaction contrast
(F1,9  5.2, P  0.049). This difference in response to
ZSTK474 was not observed in the absence of crocidolite
(F1,9  0.7, P  0.42). On the other hand, the mTOR
inhibitor rapamycin also reduced the magnitude of the
MTT signal in the presence of crocidolite (F1,9  20.3,
P  0.0015; Figure 6D), but the effect did not differ
among the groups of clones (F2,9  0.6, P  0.59) and
more importantly not between the control and the two
groups with elevated calretinin expression (SV40 and CR;
interaction contrast F1,9  0.4, P  0.55). Thus, neither
SV40 Tag nor calretinin were involved in the mTOR-me-
diated effect on crocidolite cytotoxicity. Finally, also the
involvement of the ERK1/2 pathway was investigated us-
ing the inhibitor PD98059. The inhibitor alone (in the
absence of crocidolite) had no effect on the MTT signal
in any group of clones (white bars in Figure 6E, main
effect of PD98059 F1,9  0.4, P  0.54, PD98059 
group interaction F2,9  0.6, P  0.55). Similarly, no
effect of the inhibitor was detected in cells treated with
crocidolite (gray versus black bars in Figure 6E, main
effect of PD98059 F1,9  1.4, P  0.27, PD98059 
group interaction F2,9  1.9, P  0.20, interaction con-
trast F1,9  1.4, P  0.27; Figure 6E).
Taken together, the above results indicate that specific
blocking of PI3K/AKT signaling, but not the mTOR or
ERK1/2 signaling, eliminates calretinin’s protective effect
against asbestos-induced cytotoxicity only in cells with
high calretinin expression (ie, the SV40 and CR clones).
Thus, the PI3K/AKT signaling pathway acts as a survival
signaling pathway in the presence of crocidolite.
Discussion
Since 1996, more than 170 reports were published on
calretinin as a marker for the identification of mesotheli-
omas of the epithelioid and mixed (biphasic) type, irre-
spective whether tumorigenesis was linked to asbestos
exposure or caused by other means. Hence, the six
mesothelioma cases without asbestos exposure de-
scribed in the study by Cristaudo and co-workers12 were
also diagnosed using antibodies against calretinin, cyto-
keratin, CEA, BerEP4, and CD15. Furthermore, a large-
scale transcriptional profiling of more than 22,000 genes
has resulted in 1405 candidate genes differentially ex-
pressed among i) normal tissue (lung and pleura), ii)
mesothelioma cell lines, and iii) mesothelioma samples.54
Based on the expression profiles, mesotheliomas could
be further grouped into two classes (C1 and C2; see
Figure 2 in Gordon et al54); all four groups showed dis-
tinct up- or down-regulation of particular gene products.
Among the very few genes up-regulated in both mesothe-
lioma groups C1 and C2, as well as in mesothelioma cell
lines, while unchanged in normal tissue is calretinin (hu-
man gene name: CALB2). This has prompted us to inves-
tigate the putative role of calretinin in tumorigenesis of
mesotheliomas and the SV40-immortalized cell line
MeT-5A served as a useful model to studying in vitro
calretinin’s role. Cell culture models are considered use-
ful to identifying proteins that participate in transformation
(for a review on the role of Tag on cellular transformation
see Ahuja and colleagues55). However, the exact role(s)
played by a given protein during tumorigenesis in vivo
needs to be verified, eg, in animal models, to assess the
protein’s effects in the context of a tissue. We had access
to two MeT-5A clones that differed in their immunoreac-
tivity for calretinin and SV40 Tag and the expression
appeared highly correlated: the ATCC clone with high
calretinin expression levels also showed strong Tag ex-
pression, whereas the GE clone was almost negative for
both. Stable transfection of the GE cells with the pSV40
plasmid resulted in significantly elevated Tag and con-
comitantly, elevated calretinin levels, in the best case to
levels similar as in the ATCC clone, demonstrating that
expression of SV40 early gene products (Tag and tag)
suffices to induce up-regulation of calretinin in mesothe-
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lial cells. To test the hypothesis that SV40 Tag counter-
acts the cytotoxic effects of asbestos fibers, and thus
acts as a co-carcinogen,2 we exposed the SV40-trans-
fected cells to various crocidolite concentrations. Clearly,
SV40 clones with higher calretinin and Tag expression
levels were better protected than the untransfected GE
clone and the mock-transfected clones, which had nei-
ther significantly elevated SV40 Tag nor calretinin expres-
sion levels. Also, transfected clones with only slightly
elevated calretinin expression levels were not better pro-
tected against asbestos cytotoxicity than the control
clones.
Evidently, the calretinin gene CALB2 is not the only
gene affected by SV40 transfection. Aberrant methylation
of genes after SV40 infection of mesothelial cells includes
the tumor suppressor gene RASSF1A and other genes
such as RRAD and TMS1.13 Increased methylation status
of these genes in cell lines and mesotheliomas is corre-
lated with the presence of SV40 sequences. Conse-
quently, increased methylation of TMS1 and hypermethy-
lated in cancer (HIC-1) in mesothelioma patients strongly
correlate with decreased survival time. SV40 transforma-
tion of human mesothelial cells (HMCs) also induces cell
survival via AKT activation and AKT activity is further
increased in HMCs exposed to asbestos. SV40-trans-
formed cells are also more resistant to Onconase, one of
the few chemotherapeutic agents used in patients with
malignant mesothelioma.56 Thus, the combined effects of
asbestos and SV40 on AKT-dependent signaling path-
ways have been proposed to progressively induce trans-
formation of HMCs.51
Hence, to directly assess the putative cytoprotective
effect of calretinin, MeT-5A GE cells were stably trans-
fected with a calretinin expression plasmid. Although
the calretinin-transfected clones were not conferring a
similar degree of asbestos resistance compared with
the SV40-transfected group, the resistance among the
calretinin-transfected clones as a group was signifi-
cantly higher than in the mock-transfected clones and
the cytoprotective effect in clone CR34 was almost as
potent as in the SV clones. Thus, up-regulation of cal-
retinin alone cannot fully account for the protective effect
attributable to SV40 early gene expression, but calretinin
appears as a major factor contributing to the resistance
to asbestos toxicity. In support of our hypothesis, CR
clones could be rendered more sensitive again to the
cytotoxic effects of crocidolite by calretinin down-regula-
tion using either CR antisense oligonucleotides or CR
siRNA. The effect of the reversal (11 to 26% by ASO
treatment) was of similar magnitude as the initial protec-
tion by calretinin (20 to 30%) consistent with a direct
role for calretinin in this process. The fact that the reversal
was not complete can be likely attributed to the maximal
attainable down-regulation, which rarely exceeds 80 to
90% using antisense methods. However, the net differ-
ence between the CR clones and control clones sub-
jected to either CR ASO- or siRNA treatment were essen-
tially the same, in the order of 20%.
The exact mechanism how calretinin might contribute
to tumorigenesis of mesotheliomas remains unknown. In
colon carcinoma cells down-regulation of calretinin leads
to a blockage of the cell cycle finally leading to increased
apoptosis.34 Furthermore, butyrate, an inducer of differ-
entiation in colonocytes, which also blocks the cell cycle,
down-regulates calretinin expression in colon cancer
cells.57 Although principally distributed in the cytosol,
calretinin can also associate with cytoskeletal struc-
tures33 and is found in particulate fractions of brain ho-
mogenates.58 A developmentally regulated calretinin ac-
cumulation beneath the plasma membrane in neurons59
and a nuclear localization in tumor cells under specific
conditions57 is indicative of additional roles besides
Ca2-buffering. Little is known on CALB2 gene regula-
tion: an AP2-like sequence was reported to drive neuron-
specific calretinin expression60 by binding a yet uniden-
tified nuclear protein resulting in an increased CALB2
gene promoter activity. In contrast, the AP2-like se-
quence appears not to be involved in the regulation of
CALB2 gene transcription in adenocarcinoma and me-
sothelioma cells, indicating that CALB2 gene regulation
in neurons and cancer cells occurs via different mecha-
nisms.61 Calretinin expression in tumor cells correlates
with their proliferative state and possibly increases their
resistance toward differentiating or pro-apoptotic signals.
This might be possibly clinically exploited in the case of
mesotheliomas. Mesothelioma cells transfected with a
plasmid containing part of the CALB2 promoter followed
by the thymidine kinase gene were 100-fold more sensi-
tive to the drug ganciclovir in vitro than the untransfected
cells,62 and the authors suggested that the CALB2 pro-
moter might be a promising candidate as a specific and
efficient promoter in malignant mesotheliomas. As dis-
cussed above, calretinin’s protective effect was medi-
ated via the AKT signaling pathway, because blocking it
by PI3K inhibitors abrogated calretinin’s protective effect.
Also, tumor necrosis factor- protects mesothelial cells
from asbestos cytotoxicity via a nuclear factor-B-medi-
ated pathway and was proposed to play a role in the
mechanism of mesotheliomagenesis.63 Thus, the ob-
served cytoprotective effect induced by either tumor ne-
crosis factor- or calretinin points out that the likely key to
asbestos carcinogenesis is induction of resistance mech-
anisms to the cytotoxic effects of asbestos or possibly
other asbestos-like materials such as carbon nanofi-
bers.64 It remains to be shown whether tumor necrosis
factor- affects calretinin expression and whether AKT
signaling and nuclear factor-B signaling possibly act
synergistically and/or merge on a final common pathway.
Our results further indicate that part of the protective
effect against crocidolite cytotoxicity may also be medi-
ated by the mTOR pathway, in line with findings by Wilson
and colleagues65 who reported that mTOR signaling me-
diates survival of small primary mesothelioma samples
grown ex vivo. However the protection reported in our
study was similar in all clones suggesting that neither Tag
nor calretinin were involved in the mTOR-mediated pro-
tection. Finally, the ERK signaling pathway has also been
reported to play a role in asbestos fiber-mediated trans-
formation of mesothelial cells66 and pERK was proposed
as a new molecular therapeutic target.67 Conversely, the
absence of differences in ERK activation in reactive me-
sothelium and malignant mesothelioma was used as an
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argument against an involvement in the transformation of
benign to malignant mesothelium.68 Our results support
the latter viewpoint: they indicate that inhibition of ERK
phosphorylation has no adverse effect on the acute cy-
totoxicity investigated in our study.
In summary, the overexpression of calretinin in immor-
talized mesothelial cells (CR clones) can to a large extent
replicate the cytoprotective effects observed in SV40-
transfected clones. In both cases, the activation of the
PI3K/AKT signaling pathway is involved in the increased
survival after asbestos exposure. Because calretinin ex-
pression is observed in practically all asbestos-related
mesotheliomas,27,28 and we demonstrated here that
transfection with an SV40 early gene region is sufficient to
increase calretinin expression, elevated levels of this pro-
tein in mesothelial cells may be the common underlying
cause leading to the increased resistance to signals (eg,
asbestos fibers) normally leading to cell death. In such a
way, affected mesothelial cells may escape senescence,
accumulate additional mutations finally leading to a fully
transformed state. Mechanisms of selectively blocking
calretinin function and/or down-regulating its expression
may be envisaged as a strategy to combat the develop-
ment of mesotheliomas. In the light of the fact that me-
sotheliomagenesis is a very slow process, intervention at
a time point much passed of the initial exposure may still
be of therapeutic relevance.
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